Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence
Science and Technology Nexus · 11.07.2026 · 1-7
DOI: 10.25259/stn_16_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science and Technology Nexus, online erschienen am 11.07.2026. Verfasst von Mohamed S. Sedeek und 5 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Glycyrrhiza glabra L. (licorice), renowned in ethnopharmacology, harbors bioactive metabolites such as glycyrrhizin, liquiritin, and flavonoids that confer antiviral, anti-inflammatory, antioxidant, and immunomodulatory properties pertinent to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This review appraises in vitro, in silico , preclinical, and clinical data, revealing glycyrrhizin’s potent inhibition of SARS-CoV-2 main protease (Mpro; EC50 ≈ 0.44 mg/mL in Vero E6 cells) and disruption of envelope protein lipid interactions, alongside suppression of cytopathic effects and plaque formation. Anti-inflammatory efficacy stems from downregulated nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), and cytokines (tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6)), mitigating cytokine storms, while immunostimulant effects include T-/B-lymphocyte proliferation and natural killer cell activation. Preliminary randomised trials (n=20-70) in mild-moderate coronavirus disease 2019 (COVID-19) demonstrate symptom alleviation (cough, dyspnea; p
Zitieren
APA
Sedeek, M. S., Ahmed, N. M., Ahmed, S. M., Bakr, A. A., Khaled, D., & Farouk, H. W. (2026). Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence. Science and Technology Nexus, 0, 1-7. https://doi.org/10.25259/stn_16_2026
Vancouver
Sedeek MS, Ahmed NM, Ahmed SM, Bakr AA, Khaled D, Farouk HW. Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence. Science and Technology Nexus. 2026;0:1-7. doi:10.25259/stn_16_2026
BibTeX
@article{Sedeek2026,
author = {Sedeek, Mohamed S. and Ahmed, Nesma M. and Ahmed, Salma M. and Bakr, Asmaa A. and Khaled, Donia and Farouk, Hebattallah W.},
title = {Therapeutic Potential of Glycyrrhiza glabra (Licorice) Against COVID-19: Mechanistic Insights and Technological Advances from In Silico, Preclinical and Clinical Evidence},
journal = {Science and Technology Nexus},
year = {2026},
volume = {0},
pages = {1--7},
doi = {10.25259/stn_16_2026}
}
EUVIMED